A phase Ia/b, open-label, multicentre study of the TRAILR2 agonist BI 905711 in patients (pts) with advanced gastrointestinal (GI) cancers Meeting Abstract
| Authors: | Harding, J. J.; Hofheinz, R. D.; Elez Fernandez, M. E.; Kuboki, Y.; Rasco, D.; Cecchini, M.; Shen, L.; Archuadze, S.; Geng, J.; Haderk, F.; Pant, S. |
| Abstract Title: | A phase Ia/b, open-label, multicentre study of the TRAILR2 agonist BI 905711 in patients (pts) with advanced gastrointestinal (GI) cancers |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S706 |
| Language: | English |
| ACCESSION: | WOS:000866211600365 |
| DOI: | 10.1016/j.annonc.2022.07.509 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 371P -- Source: Wos |
